| License: Creative Commons Attribution 4.0 PDF - Published Version (713kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-493430
- DOI to cite this document:
- 10.5283/epub.49343
This publication is part of the DEAL contract with Springer.
Abstract
Introduction The demand for prophylactic mastectomy has increased significantly over the last 10 years. This can be explained by a substantial gain of knowledge about the clinical risk and outcome of patients with high risk mutations such as BRCA1 and 2, the improved diagnostic possibilities for detecting the genetic predisposition for the development of breast cancer and the awareness for those ...

Owner only: item control page